Sleep symptoms and long-term outcome in adolescents with major depressive disorder : a naturalistic follow-up study by Adolescent Depression Study Grp et al.
Vol.:(0123456789) 
European Child & Adolescent Psychiatry (2020) 29:595–603 
https://doi.org/10.1007/s00787-019-01436-z
ORIGINAL CONTRIBUTION
Sleep symptoms and long‑term outcome in adolescents with major 
depressive disorder: a naturalistic follow‑up study
Anna S. Urrila1,2  · Olli Kiviruusu1,2 · Henna Haravuori1,2 · Linnea Karlsson3,4 · Satu Viertiö1 · Jaana Suvisaari1 · 
Mauri Marttunen1,2 · The Adolescent Depression Study Group
Received: 9 March 2019 / Accepted: 31 October 2019 / Published online: 6 November 2019 
© The Author(s) 2019
Abstract
Sleep abnormalities in major depressive disorder (MDD) have been suggested to represent a vulnerability trait, which might 
predispose the individual to long-term psychiatric morbidity. In this study, we sought to assess whether the presence of sleep 
symptoms among adolescents with MDD is associated with poorer long-term outcome in young adulthood during natu-
ralistic follow-up. Adolescent outpatients diagnosed with MDD (n = 166; age 13–19 years, 17.5% boys) were followed up 
during 8 years in naturalistic settings. N = 112 adolescents (16.1% boys) completed the 8-year assessment. Sleep symptoms 
and psychosocial functioning were assessed with structured clinical interviews, and depressive and anxiety symptoms with 
questionnaires. The severity of sleep symptoms at baseline was not associated with worse outcome at 8 years in terms of any 
of the outcome measures tested. In particular, the presence of a disturbed sleep–wake rhythm at baseline was associated with 
a more favourable outcome at 8 years: less depression and anxiety symptoms and higher level of psychosocial functioning. 
The presence of sleep symptoms in young adulthood was associated with the presence of current depression and anxiety 
symptoms and poorer psychosocial functioning. The presence of sleep symptoms at follow-up seems to be state-dependent: 
they are observed in conjunction with other psychiatric symptoms. Contrary to our hypothesis, our results suggest that sleep 
complaints among adolescents with MDD do not lead to poorer long-term clinical outcome in young adulthood. The link 
between sleep–wake rhythm disturbance and better long-term outcome needs to be confirmed and examined in detail in 
further studies, but here we speculate about possible explanations.
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Background
Sleep symptoms are common in depressed adolescents [1, 
2]. The presence of sleep problems in depressed adolescents 
is linked with a more severe clinical picture: a higher sever-
ity of depression, occurrence of suicidal thoughts, and worse 
overall psychosocial functioning [1–3].
Sleep symptoms are also common residual symptoms 
during recovery from depression [4–8], and their persistent 
presence during the treatment phase has been associated 
with depression at 6-month post-treatment follow-up [9]. 
In our previous study of adolescent outpatients with major 
depressive disorder (MDD), the presence of sleep symptoms 
at baseline was not associated with worse 1-year outcome 
in naturalistic settings: depressed adolescents with sleep 
symptoms showed steeper clinical improvement than oth-
ers from their index episode of depression, and the presence 
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of sleep disturbances at follow-up was related to depressive 
state [10].
It has been theorized, however, that rather than being a 
state-dependent feature of depression, sleep abnormalities 
might represent a persistent trait or a vulnerability marker, 
which might predispose the individual to long-term psy-
chiatric morbidity, including recurrent depression [11–14]. 
Sleep is designated by the Research Domain Criteria 
(RDoC) initiative of the National Institute of Mental Health 
as a transdiagnostic factor which may contribute to the 
pathophysiology of different psychiatric disorders [15, 16], 
extending our interest beyond merely depression symptoms 
to related anxiety symptoms and overall psychosocial func-
tioning. Previous studies have mainly focused on polysom-
nographic measures of sleep in mixed samples of depressed 
children and adolescents with a wider age range [13, 14] and 
in high-risk groups of adolescents [12]. Studies on the extent 
to which subjective sleep problems are associated with long-
term (> 1 year) outcome in depressed adolescents are, to the 
best of our knowledge, non-existent to date.
In this study, we sought to assess whether the presence of 
sleep symptoms among adolescents with MDD is associated 
with poorer long-term (8 years) outcome during naturalis-
tic follow-up. Our hypothesis was that sleep complaints at 
baseline would be associated with the presence of mood and 
anxiety symptoms and poorer psychosocial functioning at 
8 years and more days spent ill during the 8-year follow-up 
period. We also assessed the prevalence of sleep symptoms 
at 8-year follow-up and, further, conducted exploratory anal-
yses on the association of different types of sleep complaints 
at baseline and 8-year outcome.
Methods
The present study is part of the Adolescent Depression Study 
(ADS), which is a naturalistic clinical research study aimed 
at investigating adolescents’ depressive mood disorders. 
More detailed descriptions of the recruitment process, par-
ticipants, assessments, and outcomes have been previously 
published [17, 18].
Subjects
At baseline, the Adolescent Depression Study sample com-
prised of a total of n = 218 consecutive outpatients with any 
depressive mood disorder, of which n = 172 suffered from 
major depressive disorder (MDD) meeting the DSM-IV cri-
teria. Patients with missing/invalid data (n = 3), and patients 
with MDD in full remission already at baseline (n = 3) were 
further excluded, resulting in the inclusion of n = 166 adoles-
cent outpatients (age 13–19 years, 17.5% boys) in this study. 
The exclusion criteria of the ADS study included mental 
retardation, age under 13 or over 19 years, or insufficient 
knowledge of the Finnish language. The inclusion criteria 
and baseline sample characteristics have been described in 
detail previously [1, 18, 19]. The baseline sample of patients 
was collected between years 1998 and 2001, and the adoles-
cents were re-evaluated approximately 1 year and approxi-
mately 8 years later as young adults [mean time between 
baseline and 8-year follow-up 8.16 years, standard devia-
tion (SD) 1.01]. The prevalence of sleep complaints, and 
their association with other psychiatric symptoms at base-
line and at 1-year follow-up have been previously examined 
and published [1, 10], and in this report, we focus on the 
8-year follow-up results. N = 112 (67.5%; 16.1% boys) of 
the adolescents completed the 8-year follow-up interview, 
and analyses presented in this paper are based on their data. 
Sample characteristics at 8-year follow-up are presented in 
Table 1.
Table 1  Sample characteristics at 8  years for the total sample 
(n = 112)
Values are expressed as % unless otherwise stated
The items on sleep were excluded from the BDI-21 and HDRS total 
scores
Sociodemographic characteristics











 Unmarried, never cohabited 33.9
 Missing information 11.6
Clinical characteristics
 BDI-21 total score (mean ± SD) 7.5 ± 8.5
 HDRS total score (mean ± SD) 4.7 ± 5.5
 BAI total score (mean ± SD) 7.1 ± 7.9
 GAF (mean ± SD) 64.8 ± 14.9
 GAF; best during past year (mean ± SD) 66.9 ± 13.5
 % Time spent ill during 8 years (mean ± SD) 41.8 ± 28.7
 Clinically significant sleep symptoms 18.8
Treatment received between 1 year and 8 years
 Antidepressive medication 58.0
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The study was naturalistic in nature and during the 
8-year follow-up period the adolescents thus received 
“treatment as usual” of clinically defined duration [18]. 
Between 1-year and 8-year follow-up, of the participants, 
antidepressant medication was received by n = 65 (58.0%; 
information missing for n = 1), other psychiatric medica-
tion by n = 39 (34.8%; information missing for n = 2), sup-
portive psychotherapy by n = 64 (57.1%), group therapy by 
n = 15 (13.4%), family counselling by n = 30 (26.8%, infor-
mation missing for n = 1), and n = 18 (16.1%) received 
inpatient treatment at least once (Table 1).
The subjects gave written informed consent to partici-
pate and the study protocol was approved by the ethics 
committees of Helsinki University Central Hospital and 
Peijas Medical Health Care District.
Assessment of psychiatric symptoms and level 
of functioning
During the baseline and follow-up interviews, the partici-
pants were assessed with structured diagnostic interviews 
(K-SADS-PL at baseline and SCID-I at 8-year follow-up) 
[20, 21]. The diagnoses were confirmed in a diagnostic 
meeting and inter-rater reliability was good for mood dis-
orders based on randomly selected videotaped interviews 
[weighted Ƙ for a three-category variable (1 = MDD, 
2 = other mood disorder, 3 = no mood disorder) 0.87; 95% 
confidence interval (CI) 0.81, 0.93] [19, 22]. Time spent 
ill during the follow-up period (% of time) was assessed 
with the clinical interview.
Overall psychosocial functioning was assessed dur-
ing baseline and follow-up with the global assessment of 
functioning scale (GAF; numeric range of 0–100) as part 
of the DSM-IV axial diagnostic procedure according to 
DSM-IV guidelines [23]. At 8 years, also best overall psy-
chosocial functioning during the past 1 year was scored 
and analysed.
Depression symptom severity was assessed with the 
21-item Beck Depression Inventory (BDI-21) and the 
Hamilton Depression Rating Scale (HDRS). BDI-21 is 
a standardized self-report questionnaire which has been 
well studied in both adolescents and adults [24–26], while 
the HDRS is a clinician-administered depression rating 
scale [27]. In the analyses presented in this paper, the 
BDI-21 and HDRS items on sleep were excluded because 
we were interested in the relationship between sleep and 
other depression symptoms, and consequently the maxi-
mum score for BDI-21 in our analyses was 60 points and 
for HDRS 46 points.
Anxiety symptoms were assessed with the 21-item Beck 
Anxiety Inventory (BAI), a self-report measure of anxiety 
symptoms with a maximum score of 63 points [28].
Assessment of sleep symptoms
At baseline, sleep complaints were assessed with the 
K-SADS-PL attachment for assessment of affective disor-
ders, which includes six items about the following sleep 
symptoms: initial insomnia, middle insomnia, terminal 
insomnia, sleep–wake rhythm disturbance, non-restorative 
sleep, and hypersomnia. The interviewer rates each symp-
tom as non-existent, sub-threshold, or clinically significant 
according to standard criteria, explained in detail previously 
[1].
For assessment of sleep symptom severity at baseline, a 
continuous measure (sleep complaint severity score) was 
formed based on the total sum of all six K-SADS-PL sleep 
item scores at baseline (1–3 points per item, minimum 6 
points, maximum 18 points; missing answers (n = 4 in total) 
were substituted with the average points of all items of the 
respective participant’s answers). The assessment of sleep 
complaint severity was identical to that used in our previ-
ous publication [10]. The participants were then divided 
into three sleep subgroups based on the amount sleep com-
plaints at baseline; subgroups A (6–9 points; n = 33; no/mild 
sleep complaints), B (10–13 points; n = 61; moderate sleep 
complaints), and C (14–18 points; n = 18; severe sleep com-
plaints). As an alternative approach, we further compared 
the adolescents with multiple sleep disturbances (n = 32) at 
baseline with those with no or only one complaint of sleep 
disturbance (n = 76), which was similarly an approach used 
in our previous publication [1].
As the K-SADS-PL was not administered in young adult-
hood, an approximate of the presence/absence of clinically 
significant sleep symptoms at 8-year follow-up was obtained 
with the SCID-I interview (one item on sleep disturbances; 
hypersomnia/insomnia nearly every day for 2 weeks; rated as 
non-existent/sub-threshold/clinically significant symptoms). 
All items related to MDD (including the item on sleep) 
were asked from all participants regardless of the amount 
of reported core symptoms of MDD.
Statistical analyses
Statistical analyses were performed with the IBM SPSS 
Statistics Version 25. To assess cross-sectional differences 
between sleep subgroups Chi square tests and independent 
samples Mann–Whitney U tests (non-normal distribution 
of the data) were used. To assess the associations between 
baseline sleep complaints and 8-year outcomes, a series of 
linear regression analyses were performed. In regression 
analyses, logarithmic transformations were performed for 
all parameters with a skewed distribution before entering the 
parameters in the model. First, the crude univariate associa-
tions were analysed. Second, the models were adjusted for 
gender and age at baseline. Third, the models were adjusted 
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for gender, age, and value of respective outcome variable at 
baseline when applicable. Finally, the model was adjusted 
for gender, age at baseline, and baseline values of BDI-21, 
BAI, and GAF, except for outcome HDRS at 8 years, where 
the model was adjusted for gender, age at baseline, and base-
line values of HDRS (instead of BDI-21), BAI, and GAF. 
For all analyses, a p value of < 0.05 was considered statisti-
cally significant.
Results
Sleep symptoms at 8 years and other psychiatric 
symptoms
At 8  years, 18.8% (n = 21) of the participants suffered 
from clinically significant sleep symptoms, while 20.5% 
(n = 23) had sub-threshold sleep symptoms, and the rest 
(n = 68; 60.7%) did not report any sleep symptoms. As com-
pared with participants without clinically significant sleep 
symptoms at 8 years, those suffering from clinically signifi-
cant sleep symptoms at 8 years had higher depression symp-
tom severity (BDI-21 and HDRS total score), worse current 
and past 1 year psychosocial functioning, and higher anxiety 
symptom severity (BAI) (independent samples Mann–Whit-
ney U tests p < 0.001), while no significant difference was 
observed in time spent ill during the total follow-up period 
(independent samples Mann–Whitney U test n.s.).
Baseline sleep complaints and 8‑year outcome
The results of the regression analyses are shown in Tables 2 
and 3. Baseline sleep complaint severity subgroup was 
associated with BDI-21 and HDRS total score at 8 years 
as well as GAF at 8 years consistently across all regression 
models tested (Table 2; Fig. 1). Baseline sleep complaint 
severity subgroup was not associated with BAI at 8 years 
and best GAF during the past 1 year at 8 years in the crude 
univariate model, but when the analyses were controlled for 
baseline values of BAI and best GAF during past one year, 
Table 2  Baseline sleep complaint severity and clinical outcome at 8 years; regression analyses
Subgroup A = patients with no/minor sleep complaints (sleep complaint severity score 6–9p; n = 33) was chosen as the reference group, sub-
group B = patients with moderate sleep disturbances at baseline (10–13p; n = 61), subgroup C = patients with severe sleep disturbances at base-
line (14–18p; n = 18)
Adjusted model 1 has been adjusted for gender and age at baseline
Adjusted model 2 has been adjusted for gender, age at baseline, and value of respective outcome variable at baseline
Adjusted model 3 has been adjusted for gender, age at baseline, and baseline values of BDI-21, BAI, and GAF, except for outcome HDRS at 
8 years, where the model was adjusted for gender, age at baseline, and baseline values of HDRS, BAI, and GAF
SE standard error, NA not applicable
*p < 0.05
Outcome at 8 years Crude model Adjusted model 1 Adjusted model 2 Adjusted model 3
B (SE) p B (SE) p B (SE) p B (SE) p
BDI-21 total score at 8 years
 Subgroup B − 0.23 (0.10) 0.03* − 0.29 (0.12) 0.02* − 0.33 (0.12) 0.007* − 0.35 (0.13) 0.007*
 Subgroup C − 0.22 (0.14) 0.14 − 0.29 (0.16) 0.07 − 0.30 (0.15) 0.06 − 0.23 (0.18) 0.20
HDRS total score at 8 years
 Subgroup B − 0.27 (0.09) 0.004* − 0.31 (0.11) 0.004* − 0.34 (0.10) 0.001* − 0.36 (0.11) 0.002*
 Subgroup C − 0.11 (0.13) 0.36 − 0.17 (0.13) 0.21 − 0.26 (0.13) 0.06 − 0.25 (0.16) 0.11
BAI total score at 8 years
 Subgroup B − 0.09 (0.10) 0.37 − 0.12 (0.11) 0.29 − 0.24 (0.12) 0.04* − 0.24 (0.12) 0.04*
 Subgroup C − 0.07 (0.14) 0.59 − 0.11 (0.15) 0.46 − 0.20 (0.16) 0.21 − 0.19 (0.16) 0.25
GAF at 8 years
 Subgroup B 0.07 (0.03) 0.01* 0.07 (0.03) 0.02* 0.08 (0.03) 0.01* 0.09 (0.03) 0.005*
 Subgroup C 0.03 (0.04) 0.44 0.03 (0.04) 0.43 0.04 (0.04) 0.31 0.03 (0.05) 0.50
GAF at 8 years; best during past year
 Subgroup B 0.04 (0.02) 0.08 0.05 (0.03) 0.06 0.06 (0.03) 0.02* 0.07 (0.03) 0.01*
 Subgroup C 0.01 (0.03) 0.85 0.01 (0.03) 0.74 0.03 (0.03) 0.40 0.03 (0.04) 0.44
% Time spent ill during 8 years
 Subgroup B − 0.06 (0.07) 0.43 − 0.08 (0.08) 0.37 NA NA − 0.13 (0.09) 0.16
 Subgroup C − 0.09 (0.10) 0.41 − 0.07 (0.11) 0.50 NA NA − 0.07 (0.13) 0.57
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Table 3  Baseline multiple sleep disturbances and clinical outcome at 8 years; regression analyses
Subgroup of patients with no/only minor sleep disturbances at baseline (n = 80) was chosen as the reference group as compared to patients with 
multiple sleep disturbances at baseline (n = 32)
Adjusted model 1 has been adjusted for gender and age at baseline
Adjusted model 2 has been adjusted for gender, age at baseline, and value of respective outcome variable at baseline
Adjusted model 3 has been adjusted for gender, age at baseline, and baseline values of BDI-21, BAI, and GAF, except for outcome HDRS at 
8 years, where the model was adjusted for gender, age at baseline, and baseline values of HDRS, BAI, and GAF
SE standard error, NA not applicable
*p < 0.05
Outcome at 8 years Crude univariate model Adjusted model 1 Adjusted model 2 Adjusted model 3
B (SE) p B (SE) p B (SE) p B (SE) p
BDI-21 total score at 8 years − 0.23 (0.10) 0.03* − 0.25 (0.11) 0.03* − 0.25 (0.11) 0.03* − 0.27 (0.12) 0.03*
HDRS total score at 8 years − 0.10 (0.09) 0.27 − 0.13 (0.10) 0.22 − 0.14 (0.10) 0.15 − 0.15 (0.11) 0.17
BAI total score at 8 years − 0.25 (0.09) 0.008* − 0.24 (0.10) 0.02* − 0.24 (0.10) 0.02* − 0.24 (0.11) 0.03*
GAF at 8 years 0.03 (0.03) 0.22 0.02 (0.03) 0.41 0.03 (0.03) 0.25 0.04 (0.03) 0.27
GAF at 8 years; best during past year 0.02 (0.02) 0.33 0.02 (0.02) 0.54 0.03 (0.02) 0.22 0.03 (0.03) 0.21
% Time spent ill during 8 years − 0.05 (0.07) 0.51 − 0.06 (0.08) 0.46 NA NA − 0.08 (0.09) 0.36
Fig. 1  Depression and anxiety symptom severity and psychoso-
cial functioning during follow-up according to baseline sleep com-
plaint severity subgroup. Black lines represent patients with severe 
sleep complaints at baseline (sleep complaint severity score 14–18p; 
n = 18), grey lines patients with moderate sleep symptoms at baseline 
(10–13p; n = 61), and grey dotted lines patients with no or mild sleep 
complaints at baseline (6–9p; n = 33). BL baseline. a BDI-21 and b 
HDRS subgroup mean total scores without sleep items are presented
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respectively, both associations turned statistically significant 
(adjusted model 2), and the association remained significant 
also in model 3 when other baseline covariates were con-
trolled for (Table 2). No association between sleep complaint 
severity subgroup and time spent ill during the follow-up 
period was observed in any of the models. These associa-
tions were found when comparing subgroups A (no/minor 
sleep complaints) and B (moderate sleep complaints) so that 
belonging to subgroup B was consistently associated with 
better outcomes than belonging to subgroup A. Belonging 
to subgroup C (severe sleep complaints) vs. subgroup A was 
not associated with any of the outcomes tested.
In the regression analyses using the alternative subgroups, 
the presence of multiple sleep disturbances at baseline was 
associated with BDI-21 at 8 years and BAI at 8 years con-
sistently across all tested models (Table 3). No other sta-
tistically significant associations between the presence of 
multiple sleep disturbances at baseline and 8-year outcomes 
were observed in any of the models.
Drop-out rates during the 8-year follow-up period did not 
differ between the studied sleep subgroups (Chi square tests 
n.s.).
Type of sleep complaint and 8‑year outcome
As we got unexpected results when comparing 8-year out-
comes of sleep subgroups (adolescents with moderate sleep 
complaints and adolescents with multiple sleep disturbances 
at baseline showing better outcome as young adults), we 
decided to perform additional exploratory analyses to 
assess whether a specific type of sleep complaint (insom-
nia, hypersomnia, or sleep–wake rhythm disturbance) at 
baseline would be associated with a particularly favourable 
long-term outcome. In these analyses, adolescents with 
clinically relevant insomnia (n = 61), hypersomnia (n = 24), 
and sleep–wake rhythm disturbance (n = 28) at baseline were 
compared with the group of patients who did not present 
with the respective sleep disturbance at baseline.
These analyses showed that the adolescents with clini-
cally relevant sleep–wake rhythm disturbance at baseline 
(sleeping at a different time of the day than usual more than 
once a week) differed significantly from those who did not 
present with sleep–wake rhythm disturbance at baseline in 
terms of the following 8-year outcomes: BDI-21 total score 
(independent samples Mann–Whitney U test p = 0.008), 
HDRS total score (p = 0.007), GAF (p = 0.002), best GAF 
during past year (p = 0.005), and BAI total score (p = 0.016), 
adolescents with sleep–wake rhythm disturbance at base-
line having consistently better outcomes at 8 years than 
adolescents without a sleep–wake rhythm disturbance. 
Adolescents with insomnia or hypersomnia at baseline did 
not differ significantly from adolescents without these dis-
turbances in terms of 8-year outcome (independent samples 
Mann–Whitney U tests n.s.). In all regression analysis mod-
els tested, all tested 8-year outcomes were associated with 
the presence of a sleep–wake rhythm disturbance at baseline, 
with the exception of time spent ill during the 8-year follow-
up period, which was not associated with the presence of 
sleep–wake rhythm disturbance at baseline in any of the 
models (Table 4).
As supplementary analyses, we first compared background 
information of adolescents with sleep–wake rhythm distur-
bance at baseline and the rest of the adolescents. These two 
subgroups did not differ in terms of gender distribution, age 
at baseline, parental socio-economic status, parental divorce 
rate, perceived psychosocial support, recurrence/length of 
Table 4  Baseline sleep–wake rhythm disturbance and outcome at 8 years
The subgroup of patients without sleep–wake rhythm disturbance at baseline (n = 84) was chosen as the reference group as compared to patients 
with sleep–wake rhythm disturbance at baseline (n = 32)
Adjusted model 1 has been adjusted for gender and age at baseline
Adjusted model 2 has been adjusted for gender, age at baseline, and value of respective outcome variable at baseline
Adjusted model 3 has been adjusted for gender, age at baseline, and baseline values of BDI-21, BAI, and GAF, except for outcome HDRS at 
8 years, where the model was adjusted for gender, age at baseline, and baseline values of HDRS, BAI, and GAF
SE standard error, NA not applicable
*p < 0.05
Outcome at 8 years Crude univariate model Adjusted model 1 Adjusted model 2 Adjusted model 3
B (SE) p B (SE) p B (SE) p B (SE) p
BDI-21 total score at 8 years − 0.28 (0.10) 0.008* − 0.30 (0.11) 0.009* − 0.29 (0.11) 0.01* − 0.31 (0.12) 0.01*
HDRS total score at 8 years − 0.24 (0.10) 0.02* − 0.27 (0.10) 0.008* − 0.29 (0.10) 0.005* − 0.27 (0.11) 0.01*
BAI total score at 8 years − 0.24 (0.10) 0.01* − 0.23 (0.10) 0.03* − 0.24 (0.11) 0.03* − 0.25 (0.11) 0.02*
GAF at 8 years 0.08 (0.03) 0.004* 0.08 (0.03) 0.007* 0.09 (0.03) 0.003* 0.08 (0.03) 0.01*
GAF at 8 years; best during past 1 year 0.07 (0.02) 0.004* 0.07 (0.02) 0.007* 0.08 (0.02) 0.001* 0.08 (0.03) 0.004*
% Time spent ill during 8 years − 0.04 (0.08) 0.64 − 0.03 (0.08) 0.70 NA NA − 0.04 (0.09) 0.64
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depression at baseline, level of depression/anxiety at baseline, 
psychosocial functioning at baseline, treatments received 
during the 8-year follow-up, and drop-out rate during 8-year 
follow-up (independent samples Mann–Whitney U tests and 
χ2 tests n.s.). Second, we wanted to see if normalization of 
the sleep–wake rhythm during the first 1 year of the follow-up 
would be associated with 8-year outcome. In these analyses, 
we included only those participants whose data were availa-
ble in all three time points (baseline, 1 years, 8 years; n = 97). 
The group of adolescents whose initial sleep–wake rhythm 
disturbance remitted during the 1-year follow-up (n = 18) 
had a more favourable 8-year outcome than the rest of the 
adolescents (n = 79) (Table 5). The number of adolescents 
suffering from a persistent sleep–wake rhythm disturbance 
from baseline to 1 year was unfortunately too small (n = 4) 
to be included in the statistical models.
Discussion
The main and unexpected finding of this naturalistic clinical 
long-term (8 years) follow-up study was that the presence 
of sleep symptoms among depressed adolescents was not 
associated with poorer long-term clinical outcome. On the 
contrary, baseline sleep–wake rhythm disturbance was asso-
ciated with a particularly good clinical outcome at 8 years: 
less depression and anxiety symptoms and higher level of 
psychosocial functioning.
In addition, the overall prevalence of sleep symptoms 
among the depressed adolescents in young adulthood 
(18.8%) was expectedly lower than at baseline (prevalence 
of clinically significant sleep symptoms 83%) [1] and 1-year 
follow-up (50%) [10]. As the presence of sleep symptoms in 
young adulthood was associated with the presence of current 
depression and anxiety symptoms and poorer psychosocial 
functioning, but not with time spent ill during the total study 
period, the findings of this study support the state-dependent 
association of sleep symptoms with other current psychiatric 
morbidity [9].
Our main finding is in line with our previous report in the 
same sample of participants at 1-year follow-up [10], but 
contradicts with previous findings pointing towards sleep 
abnormalities acting as predisposing factors to psychiatric 
morbidity and poor social functioning [11–14, 16, 29]. This 
discrepancy might be explained mainly by the considerably 
longer follow-up time in our current study, as well as the dif-
fering methods for assessing sleep abnormalities (objective 
sleep EEG vs. subjective reports). Polysomnographic studies 
in MDD point overall towards alterations in sleep continu-
ity, sleep depth, and REM sleep pressure [30, 31], the find-
ings being less consistent and less severe among children 
and adolescents than among adults [30–32]. In turn, subjec-
tive sleep complaints among depressed adolescents include 
insomnia or hypersomnia, experiences of insufficient sleep 
quality, and daytime sleepiness [29, 31]. Based on the cur-
rent study, we cannot rule out the possible presence/absence 
of, e.g., REM sleep changes, alterations of slow wave sleep 
(SWS), or sleep EEG coherence abnormalities in our sample. 
It is possible, that the EEG abnormalities might present a 
trait-like phenomenon, while the subjective sleep complaints 
would be more state-dependent. Despite the partial discrep-
ancy between the subjective and objective findings, subjec-
tive sleep measures provide a clinically more useful tool to 
address sleep problems experienced by the patients [33].
As most of our outcome measures at 8 years were cross-
sectional, the current study cannot answer more precise 
Table 5  Normalization of disturbed sleep–wake rhythm during 1 year and outcome at 8 years
As supplementary analyses, the depressed adolescents with sleep–wake rhythm at baseline who did not show this symptom anymore at 1-year 
follow-up (n = 18) were compared with the rest of the adolescents (n = 79; reference category)
Adjusted model 1 has been adjusted for gender and age at baseline
Adjusted model 2 has been adjusted for gender, age at baseline, and value of respective outcome variable at baseline
Adjusted model 3 has been adjusted for gender, age at baseline, and baseline values of BDI-21, BAI, and GAF, except for outcome HDRS at 
8 years, where the model was adjusted for gender, age at baseline, and baseline values of HDRS, BAI, and GAF
SE standard error, NA not applicable
*p < 0.05
Measure at 8 years Crude univariate model Adjusted model 1 Adjusted model 2 Adjusted model 3
B (SE) p B (SE) p B (SE) p B (SE) p
BDI-21 total score at 8 years − 0.29 (0.12) 0.02* − 0.30 (0.13) 0.02* − 0.30 (0.13) 0.03* − 0.30 (0.14) 0.04*
HDRS total score at 8 years − 0.23 (0.11) 0.04* − 0.25 (0.12) 0.04* − 0.27 (0.12) 0.03* − 0.27 (0.13) 0.04*
BAI total score at 8 years − 0.25 (0.12) 0.03* − 0.25 (0.12) 0.04* − 0.26 (0.13) 0.04* − 0.27 (0.13) 0.04*
GAF at 8 years 0.07 (0.03) 0.03* 0.07 (0.04) 0.04* 0.07 (0.04) 0.05* 0.07 (0.04) 0.10
GAF at 8 years; best during past y 0.07 (0.03) 0.02* 0.07 (0.03) 0.02* 0.07 (0.03) 0.02* 0.06 (0.03) 0.05*
% Time spent ill during 8 years − 0.08 (0.09) 0.42 − 0.06 (0.10) 0.54 NA NA − 0.03 (0.10) 0.74
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questions on the relationship between sleep symptoms and 
trajectories of depression during the 8-year follow-up period. 
As the sleep subgroups did not differ in terms of total time 
spent ill during the 8-year follow-up period, it seems likely 
that the adolescents with disturbed sleep at baseline were not 
constantly feeling better than the rest of the participants. The 
adolescents with disturbed sleep–wake rhythm at baseline 
showed, however, higher level of psychosocial functioning 
during the past 1 year before the 8 years assessment, mean-
ing that the association between sleep disturbances at base-
line and outcome at 8 years was not purely limited to the 
8-year time point.
The especially good 8-year outcome of depressed adoles-
cents with sleep–wake rhythm disturbance was unexpected. 
In theory, this finding might be explained by several factors 
unrelated to the nature of the sleep disturbance itself. No dif-
ferences were, however, observed between adolescents with 
sleep–wake rhythm disturbance and the rest of the adoles-
cents in background profiles, baseline psychiatric symptoms, 
and treatment received during 8 years.
If we assume that the sleep–wake rhythm disturbance 
itself would have contributed to the onset of depression in 
adolescence, it is possible that the physiological stabiliza-
tion and advance of circadian rhythms when getting older 
[34] could have benefitted the adolescents and led over time 
to alleviation of other psychiatric symptoms as well. Unfor-
tunately, no information on 8-year sleep–wake rhythm was 
available in our study. However, supporting this idea, in 
our sample of depressed adolescents, normalization of the 
sleep–wake rhythm during the first year of the follow-up 
was associated with a favourable 8-year outcome. It must 
also be noted that, in contrast to other sleep disturbances, 
sleep EEG structure itself is usually well maintained in 
sleep–wake rhythm disturbances [35, 36], potentially mak-
ing the group of adolescents with a disturbed sleep–wake 
rhythm a unique subgroup among the depressed adolescents. 
Further, since manipulations of the sleep–wake rhythm can 
be used as treatments for affective disorders [37], we can 
speculate that the deviations of the sleep–wake rhythm at 
baseline could have represented actually an (successful) 
attempt of the depressed adolescents to cope with their 
affective symptoms. As the baseline sample was collected in 
years 1998–2001 before the dramatic increase in electronic 
media use among adolescents in Finland, the cause for the 
adolescents’ sleep–wake rhythm disturbance was most likely 
unrelated to excessive electronic media use. Ultimately, the 
current findings highlight the complex link between sleep, 
circadian rhythms, and the regulation of mood.
The major strengths of this study include the clinically 
well-characterized sample of adolescents with long-term 
follow-up in naturalistic settings, the homogeneous age 
range and the use of standardized psychiatric evaluation 
instruments. Limitations include most notably the lack of 
objective measures of sleep, and lack of sleep-specific ques-
tionnaires and sleep logs (no information available on, e.g., 
habitual sleep length), as well as the lack of more detailed 
information on sleep symptoms at 8-year follow-up. Further 
limitations are the use of the GAF scale to assess psycho-
social functioning, which does not allow disentangling the 
aspects of psychopathology and social functioning, and the 
lack of detailed information of medication use (e.g., specific 
type of antidepressant, duration of medication). Finally, the 
over-representation of girls in our sample may limit the gen-
eralizability of the findings to depressed adolescent boys.
Conclusions
Baseline sleep disturbances did not have an unfavourable effect 
on clinical outcome in an 8-year naturalistic clinical follow-
up of depressed adolescents, suggesting that subjective sleep 
disturbances at baseline do not lead to poorer clinical outcome 
in young adulthood. In particular, sleep–wake rhythm distur-
bance was associated with a good outcome within the group of 
depressed adolescents. To confirm these findings and to clarify 
the link between sleep and depression in adolescents in further 
detail, future studies with larger sample sizes and objective 
measures of sleep and circadian rhythm should be conducted. 
In particular, the link between different types of sleep distur-
bances and clinical outcome warrants attention.
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